Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_provenance.
- NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_assertion description "[The mRNA level for cannabinoid receptor type 2 (CB2) was significantly increased in AD-PBMCs as compared to healthy subjects (mean���SE of arbitrary units: 0.34���0.03 vs. 0.23���0.02 in autistic children and healthy subjects, respectively), whereas CB1 and fatty acid amide hydrolase mRNA levels were unchanged.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_provenance.
- NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_assertion evidence source_evidence_literature NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_provenance.
- NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_assertion SIO_000772 23585028 NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_provenance.
- NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_assertion wasDerivedFrom befree-20150227 NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_provenance.
- NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_assertion wasGeneratedBy ECO_0000203 NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_provenance.
- befree-20150227 importedOn "2015-02-27" NP392914.RA9XrG4UrZ7dd-N3VrBQMjy4lxcpr6fJ-5JLoDbNsTQ54130_provenance.